The Predictive Toxicology Summit 2017 is dedicated to integrating mechanistic, translational and clinical strategies.
The Predictive Toxicology Summit 2017 covers topics such as:
- Predictive computational toxicology to support drug safety assessment
- Inroads to predict in vivo toxicology— an update to the eTOX project
- Human ESC and iPSC-derived cardiomyocytes for drug discovery and cardiac safety studies
- Translational Strategies for Cardiotoxicity Testing
- Safety pharmacology—stand-alone studies or incorporation into toxicology studies
- Advanced biomarkers for drug-induced liver injury (DILI)
- In silico - in vitro - in vivo relationships for drug induced phospholipidosis
- Inhibition of late sodium channel current, ranolazine and beyond: in vitro
